FDA clears soft mist inhaler trial for lung disease
FDA clears soft mist inhaler trial for lung disease Longevity.Technology
2026
Recon: FDA approves Stada’s Lucentis biosimilar; Lilly says ‘triple-G’ candidate bests Ozempic in diabetes
Recon: FDA approves Stada’s Lucentis biosimilar; Lilly says ‘triple-G’ candidate bests Ozempic in diabetes RAPS
After 30 Years, FDA Approves First-Ever Drug For a Rare Neurological Disorder
After 30 Years, FDA Approves First-Ever Drug For a Rare Neurological Disorder ScienceAlert
FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer
FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer 2 Minute Medicine